Best In Vitro Diagnostics Companies in United States
The 132 best In Vitro Diagnostics companies in United States in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: calypso medical.
Tracking the best In Vitro Diagnostics companies in the United States by disclosed equity funding, this directory covers 132 ventures with a combined $232M on the books. The global IVD market sat at $81.3B in 2023 and is forecast to reach $129.9B by 2033 at a 4.8% CAGR, which tells you the underlying demand isn't slowing. Aging populations, post-COVID diagnostics buildout, and a steady clip of M&A are all feeding that curve. And if you want a sense of where momentum is concentrating right now, GCC IVD growth is one of the sharper regional signals worth watching alongside the U.S. market.
Within our 132 tracked companies, the funding spread is striking. Calypso Medical leads at $148M, Biofire Diagnostics follows at $84M, and then the curve drops hard. No unicorns yet. That gap between the top two and the rest of the field is, I'd argue, the defining structural fact here. Hot themes right now include IVF cycle monitoring and IVF stimulation protocols, which suggests a meaningful pivot toward reproductive health applications inside the broader diagnostics tent. Stringent regulatory frameworks keep the entry bar high, which partly explains why so many companies in this directory show zero disclosed funding. The ones that do raise are raising deliberately.
Ranked: Best In Vitro Diagnostics companies in United States
| # | Company | Disclosed funding | Last round | Stage | Founder | Founded | Tech stack | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|---|
| 1 | calypso medical Calypso Medical develops tumor localization systems designed to accurately and objectively track the location… | $148M | 183 mo ago | Acqui-Hired | — | 2000 | — | — | — |
| 2 | biofire diagnostics BioFire Diagnostics is a biotech company that detects pathogens and mutations for molecular diagnostics. | $84M | 43 mo ago | Acquired | — | 1990 | WordPressApple iCloud MailMicrosoft 365+27 | 227 patents Integrated rapid cell lysis and nucleic‑acid extraction for point‑of‑care infectious diagnostics | — |
| 3 | AboGen At AboGen, we believe that drawing large volumes of blood using invasive needles for research and diagnostic… | — | — | Deadpooled | — | 2012 | — | 33 patents Patents concentrated in health & consumer products | — |
| 4 | Acumen Detection Developer of PCR technology designed to identify mastitis-causing pathogens in hours. | — | — | Private | — | 2019 | — | 4 patents Rapid microbiological testing of milk and detection of ricin/toxin biomarkers | — |
| 5 | Adeza Biomedical Learn about the importance of Pap testing and the HPV (human papilloma virus) vaccine. | — | — | — | — | — | — | 24 patents Oncofetal fibronectin biomarker assays for pregnancy and cancer diagnostics | — |
| 6 | adipomics Adipomics is a biotechnology company that engages in improving diagnostics and treatment around childhood… | — | — | Private | — | 2015 | — | — | — |
| 7 | Advanced Medical Specialties Hematology and Oncology | — | — | — | — | — | — | — | — |
| 8 | AEENA Dx Developer of biofluid-based molecular diagnostic tests designed to make breast cancer detection accurate… | — | — | Acquired | — | 2010 | — | 10 patents Molecular diagnostic assays using nucleic acid detection for disease identification | — |
Top 2 In Vitro Diagnostics companies in United States
#1
Acquired · Salt Lake City, Utah · founded 1990 · 848 employees$84Mraised▾
Provider of syndromic infectious disease diagnostic services designed to offer accurate results to patients. The company's services include real-time thermocycling, mutation scanning and set the standard for molecular diagnostics through its pioneering advances in syndromic infectious disease testing, and it also has panels to test for viruses, bacteria, and antimicrobial resistance genes, enabling medical businesses to assess the cure of diseases in infants and adults.
#2
Acqui-Hired · Seattle, Washington · founded 2000 · 175 employees$147.8Mraised▾
Calypso Medical develops tumor localization systems designed to accurately and objectively track the location of tumors in human bodies.
Funding & investor landscape
Market landscape — 10 sub-themes by coverage
Share of In Vitro Diagnostics coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
How research on Diagnostics is moving in the United States
A read on the academic research around Diagnostics — which themes are gaining ground, the institutions and researchers driving them, and how the tone is shifting. Based on 8,526 United States-affiliated papers.
- Harvard University330
- Johns Hopkins University318
- Heidelberg University249
- Massachusetts General Hospital214
- The University of Texas MD Anderson Cancer Center191
- Liquid biopsy125→427
- Biopsy15→114
- Biomarker17→103
- Point-of-care testing112→195
- Cancer67→146
- Liquid biopsy183→739
- Biopsy42→285
- Biomarker55→208
- Cancer115→260
- Oncology57→183
- Liquid biopsy67→239
- Biopsy17→99
- Biomarker28→86
- Coronavirus disease 2019 (COVID-19)1→44
- Cancer55→92
Where diagnostics is researched across United States
Location clusters by institution affiliation — each city's volume, stance tone, and a quick read on its hot topic, what's advancing, the opening opportunity, and the main concern.
Who's filing diagnostics patents in the United States
United States diagnostics patent filing is accelerating — 418 filings from 196 assignees (2016–2025), led by Detect, UNIV Leland Stanford Junior, Washington University ST Louis; annual filings 13→55.
- Detect42
- UNIV Leland Stanford Junior33
- Washington University ST Louis20
- Nuclein19
- UNIV California19
- Texas A & M UNIV SYS19
- Tempus LABS18
- New England Biolabs18
Common questions
Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.